Unlike the others, infrared saunas work efficiently at lower temperatures
The thyroid concern for GLP-1 medications represents a theoretical risk that has not materialized in human data
Results are expected in 2028, after which Roche can pursue regulatory approval if the findings are positive
Key Takeaways Side effects are predictable, dose-dependent, and time-limited for most patients Nausea typically peaks within 48 weeks and improves with body adaptation Each dose escalation produces a temporary, milder return of symptoms Weeks 26 are when most patients quit this is the wrong time to stop Protein, hydration, and resistance training prevent the most common long-term issues (muscle loss, fatigue, constipation) Serious side effects are uncommon but recognisable knowing the warning signs matters If symptoms are unmanageable, ask your prescriber to delay (not skip) a dose escalation References Hawkins-Jarrett ZC, PharmD
GSH-Plus provides L-Glutathione, fortified with N-acetyl-L-cysteine and glycine